Patent details

Basic Information

Publication number:

EP2892535

PCT Application Number:

US2013057432

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP138350194

PCT Publication Number:

WO2014039375

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD OF ADJUVANT CANCER TREATMENT

French Title of Invention:

PROCÉDÉ DE TRAITEMENT DU CANCER PAR ADJUVANT

German Title of Invention:

VERFAHREN FÜR EINE KREBSHILFSTHERAPIE

SPC Number:

Dates

Filing date:

30/08/2013

Grant date:

22/09/2021

EP Publication Date:

15/07/2015

PCT Publication Date:

13/03/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/09/2021

EP B1 Publication Date:

22/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

30/08/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/09/2021

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

LAQUERRE, Sylvie

Address:

United States (US)

2

Name:

LEBOWITZ, Peter F.

Address:

United States (US)

Priority

Priority Number:

201261696375 P

Priority Date:

04/09/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/519; A61K 31/506; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202138

Publication date:

22/09/2021

Description:

Grant (B1)

2

Issue number:

202230

Publication date:

27/07/2022

Description:

Opposition procedure started

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

13

Annual Fee Amount:

180 Euro

Expected Payer:

Last Annual Fee Payment Date:

14/08/2024

Last Annual Fee Paid Number:

12

Last Annual Fee Paid Amount:

165 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages